1. Home/
  2. Compounds/
  3. sirolimus:bortezomib (250:1 mol/mol)

sirolimus:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2sirolimus:bortezomib (250:1 mol/mol)
PharmacoGx sirolimus:bortezomib (250:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to sirolimus:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ZNF713 CTRPv2 pan-cancer AAC 0.12 0.0003
mRNA ZNF720 CTRPv2 pan-cancer AAC 0.087 0.01
mRNA ZNF737 CTRPv2 pan-cancer AAC 0.1 0.003
mRNA ZNF746 CTRPv2 pan-cancer AAC 0.097 0.005
mRNA ZNF764 CTRPv2 pan-cancer AAC 0.092 0.007
mRNA ZNF766 CTRPv2 pan-cancer AAC 0.13 0.0002
mRNA ZNF775 CTRPv2 pan-cancer AAC 0.14 0.0003
mRNA ZNF786 CTRPv2 pan-cancer AAC 0.18 1e-07
mRNA ZNF804A CTRPv2 pan-cancer AAC 0.11 0.002
mRNA ZNF821 CTRPv2 pan-cancer AAC 0.16 8e-06
Download CSV